Fountaintown, IN, United States of America

Lee A Phebus


Average Co-Inventor Count = 3.1

ph-index = 5

Forward Citations = 94(Granted Patents)


Company Filing History:


Years Active: 1997-2002

Loading Chart...
9 patents (USPTO):Explore Patents

Title: Lee A Phebus: A Pioneer of Invention

Introduction: Lee A Phebus, a prolific inventor hailing from Fountaintown, IN (US), stands as a shining example of the power of innovation and the significance of pushing boundaries in the quest for a better future. His inventive spirit continues to inspire others and cement his status as a true pioneer in the realm of inventions.

Latest Patents: Lee A Phebus has a remarkable total of 9 patents to his name. Among his latest groundbreaking inventions are methods for treating or ameliorating the symptoms of the common cold or allergic rhinitis using serotonin 5-HT1F agonists, as well as the development of 5-HT1F antagonists. These patents showcase his dedication to improving healthcare and advancing medical treatments.

Career Highlights: Lee A Phebus is currently affiliated with Eli Lilly and Company, a renowned pharmaceutical company known for its innovative contributions to the healthcare industry. His work at Eli Lilly and Company underscores his commitment to driving progress and making a meaningful impact in the field of medicine.

Collaborations: Throughout his career, Lee A Phebus has collaborated closely with talented individuals such as Kirk Willis Johnson and Sandra Ann Filla. These partnerships have played a pivotal role in shaping his inventive journey and have led to the development of groundbreaking solutions in healthcare.

Conclusion: Lee A Phebus's outstanding achievements in the world of inventions highlight his unwavering dedication to driving progress and creating positive change. His innovative spirit, coupled with his collaborative efforts, continues to set new benchmarks in the realm of medical advancements, inspiring generations to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…